Syncona : SwanBio Evolves Leadership Team with Appointment of Executive Chair and Chief Operating Officer -October 16, 2023 at 06:41 am EDT

SwanBio Therapeutics, a gene therapy company developing AAV-based therapies for the treatment of devastating, inherited neurological conditions, today announced the addition of two industry...

Related Keywords

Aytu Biopharma ,John Tsai ,Chris Hollowood ,Lara Furst ,Syncona Swanbio ,Tom Anderson ,European Medicines Agency ,Amgen ,Syncona Ltd ,Drug Administration ,Novartis ,Syncona Investment Management ,Swanbio Therapeutics ,Topher Brooke ,Syncona Investment Management Limited ,Forcefield Therapeutics ,Rumpus Therapeutics ,Bio Therapeutics ,Fast Track ,Orphan Drug Designation ,European Medicines ,Mass General Brigham ,Markets ,